Evidence-based guideline on the primary care management of asthma.

This is an updated version of the first North of England Asthma Guideline (1,2) and summarizes the full guideline. (3) This paper presents all the recommendations within the guideline and, where these are new or substantially altered from the original version, it also presents a summary of the supporting evidence. The aims and methods of development (summarized in Box 1) of this guideline are unchanged from the original version, to which readers are directed for more detail. The research questions raised during the development of this guideline are shown in Box 2.

[1]  D. Bereczki,et al.  The Cochrane Database of Systematic Reviews , 2003 .

[2]  R. Puy,et al.  Allergen immunotherapy for asthma. , 2003, Cochrane Database of Systematic Reviews.

[3]  P. Gøtzsche,et al.  House dust mite control measures for asthma. , 2001, The Cochrane database of systematic reviews.

[4]  P. Gøtzsche,et al.  House dust mite control measures for asthma. , 2001, The Cochrane database of systematic reviews.

[5]  K. Linde,et al.  Homeopathy for chronic asthma. , 2000, The Cochrane database of systematic reviews.

[6]  L. Dubé,et al.  A Randomized Controlled Trial Comparing Zileuton With Theophylline in Moderate Asthma , 1998 .

[7]  Can Do,et al.  Smoking cessation: what the health service can do , 1998, Evidence-Based Dentistry.

[8]  D. Birnkrant.  Leukotriene Antagonist Prevents Exacerbation of Asthma During Reduction of High-Dose Inhaled Corticosteroid , 1997 .

[9]  J. Kemp,et al.  Dose‐related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene–receptor antagonist, at the end of a once‐daily dosing interval , 1997, Clinical pharmacology and therapeutics.

[10]  D. Prezant,et al.  Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered? , 1997, Chest.

[11]  A. Kelly,et al.  Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. , 1997, The Journal of allergy and clinical immunology.

[12]  J. Kemp,et al.  Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group. , 1997, Clinical therapeutics.

[13]  N. Barnes,et al.  Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma. , 1997, Thorax.

[14]  D. Postma,et al.  Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. , 1997, Thorax.

[15]  Lesley Rushton,et al.  Effect of long term treatment with salmeterol on asthma control: a double blind, randomised crossover study , 1997, BMJ.

[16]  S. Spector,et al.  Salmeterol versus theophylline in the treatment of asthma. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  S. Suissa,et al.  Effectiveness of the Leukotriene Receptor Antagonist Zafirlukast for Mild-to-Moderate Asthma , 1997, Annals of Internal Medicine.

[18]  P. Paré,et al.  The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. , 1997, Chest.

[19]  J Zhang,et al.  Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. , 1997, Thorax.

[20]  L. Boulet,et al.  A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study. , 1997, The Journal of allergy and clinical immunology.

[21]  D. Hendrick,et al.  THE DURATION OF ACTION OF INHALED FORMOTEROL DRY POWDER , 1996, The British journal of clinical practice.

[22]  M. Levy,et al.  Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. , 1996, Thorax.

[23]  L. Jacques,et al.  Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group. , 1996, The European respiratory journal.

[24]  C. Fanta,et al.  A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. , 1996, Chest.

[25]  A. Schreurs,et al.  A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients. , 1996, The European respiratory journal.

[26]  P. Paggiaro,et al.  Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group. , 1996, The European respiratory journal.

[27]  J. V. van Noord,et al.  Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. , 1996, The European respiratory journal.

[28]  P. Leblanc,et al.  A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma. , 1996, American journal of respiratory and critical care medicine.

[29]  A. Woolcock,et al.  Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. , 1996, American journal of respiratory and critical care medicine.

[30]  E. Israel,et al.  Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. , 1996, JAMA.

[31]  J. Bousquet,et al.  Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[32]  G. Boyd.  Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group. , 1995, The European respiratory journal.

[33]  I. Steffensen,et al.  * Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease , 1995, Allergy.

[34]  S. Ho,et al.  Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids. , 1995, Chest.

[35]  G. Guyatt,et al.  Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. , 1995, American journal of respiratory and critical care medicine.

[36]  P. Faurschou,et al.  Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies , 1994, Allergy.

[37]  K. Jones,et al.  Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group. , 1994, Thorax.

[38]  S. Spector,et al.  Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. , 1994, American journal of respiratory and critical care medicine.

[39]  G. Alonzo.  Salmeterol Xinafoate As Maintenance Therapy Compared With Albuterol in Patients With Asthma. , 1994 .

[40]  C. Chastang,et al.  Salmeterol compared with slow‐release terbutaline in nocturnal asthma A multicenter, randomized, double‐blind, double‐dummy, sequential clinical trial , 1994, Allergy.

[41]  L. Brochard,et al.  Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. , 1994, American journal of respiratory and critical care medicine.

[42]  J. Kemp,et al.  A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. , 1994, Chest.

[43]  O. Zetterström,et al.  Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease. , 1994, Respiration; international review of thoracic diseases.

[44]  W. Busse,et al.  The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma , 1993, Annals of Internal Medicine.

[45]  K P Jones,et al.  Guidelines on the management of asthma. , 1993, Thorax.

[46]  M. McDermott,et al.  Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. , 1993, Archives of internal medicine.

[47]  W. Castle,et al.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. , 1993, BMJ.

[48]  J. Palmer,et al.  Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. , 1993, Thorax.

[49]  J. Kemp,et al.  A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. , 1992, The New England journal of medicine.

[50]  J. Palmer,et al.  A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. , 1992, The European respiratory journal.

[51]  J. Palmer,et al.  Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease — a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol (50 μg) , 1992 .

[52]  B. H. Rowe,et al.  Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. , 1992, The American journal of emergency medicine.

[53]  M. Depolo.  Aminophylline therapy for acute bronchospastic disease in the emergency room , 1992 .

[54]  S. Andersson.  [Acupuncture for the treatment of asthma]. , 1992, Nordisk medicin.

[55]  J. Palmer,et al.  Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms). , 1992, Respiratory medicine.

[56]  J. Kleijnen,et al.  Acupuncture and asthma: a review of controlled trials. , 1991, Thorax.

[57]  B. Strom,et al.  The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. , 1991, The American journal of medicine.

[58]  N. Douglas,et al.  Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. , 1990, BMJ.

[59]  A. Tattersfield,et al.  Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma , 1990, The Lancet.

[60]  S. Linder,et al.  A Reassessment of the Additive Scoring of Health Practices , 1988, Medical care.

[61]  M. Elliott.  Aminophylline treatment in severe, acute asthma: Littenberg B JAMA 259:1678–1684 Mar 1988 , 1988 .

[62]  B. Littenberg.  Aminophylline treatment in severe, acute asthma. A meta-analysis. , 1988, JAMA.

[63]  A. Coulson,et al.  A controlled trial of real and simulated acupuncture in the management of chronic asthma. , 1985, The Journal of allergy and clinical immunology.